-
-
-
-
-
-
-
Tarsus Pharmaceuticals, Inc. (TARS) Misses Q4 EPS by 12c
-
-
-
-
-
-
-
Elanco Animal Health (ELAN) sells certain royalties and commercial milestones associated with XDEMVY to Blackstone Life Sciences and Blackstone Credit & Insurance for $295M Cash
-
-
-
-
-
-
-
Goldman Sachs Reiterates Neutral Rating on Tarsus Pharmaceuticals (TARS)
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Tarsus Pharmaceuticals (TARS)
-
-
-
-
-
413,272 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

